CAS number: 107868-30-4

General information about the Exemestane active pharmaceutical ingredient

Exemestane as active pharmaceutical ingredient (API) is hormonal antineoplastic agent. Exemestane is a medication used to treat early and advance breast cancer in women after menopause. Exemestane comes as oral tablets. Exemestane is usually prescribed after the treatment with tamoxifen.

Axplora manufactures Exemestane API

Exemestane API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Exemestane API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Exemestane API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Exemestane API.
  • Therapeutic area Anti-Cancer
  • Monograph PH.EUR.
  • Available grade Micronized
  • Regulatory documentation US DMF#
  • Produced in GRO